comparemela.com

Page 3 - Bob Zhang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Epigenic secures funds to advance gene editing therapy

Epigenic Therapeutics has secured $20m in Series Angel and Pre-A funding to proceed with next-generation gene editing therapy.

Michael xueBob zhangTrinity innovation fundKingray capitalTigeryeah capitalMorningside venture capitalSeries pre aFountainbridge capitalVenture capitalEpigenic therapeutics

Epigenic Therapeutics Raises $20M in Series Angel and Pre-A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Bob zhangTrinity innovation fundEpigenic therapeuticsSeries angelMorningside venture capitalKingray capitalTigeryeah capital

Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesHong kongMichael xueBob zhangEpigenic therapeutic technology platformPrnewswire epigenic therapeutics co ltdTrinity innovation fundSeries angelMorningside venture capitalKingray capitalFountainbridge capitalEpigenic therapeuticsManaging directorMorningside ventureEpigenic therapeuticChan family

Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy - Press Release

SHANGHAI, Aug. 6, 2022 /PRNewswire/ Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene

United statesHong kongMichael xueBob zhangEpigenic therapeutic technology platformEpigenic therapeutics co ltdTrinity innovation fundSeries angelMorningside venture capitalKingray capitalFountainbridge capitalEpigenic therapeuticsManaging directorMorningside ventureEpigenic therapeuticChan family

Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy

/PRNewswire/ Epigenic Therapeutics Co., Ltd., a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing.

United statesHong kongMichael xueBob zhangEpigenic therapeutic technology platformPrnewswire epigenic therapeutics co ltdTrinity innovation fundSeries angelMorningside venture capitalKingray capitalFountainbridge capitalEpigenic therapeuticsManaging directorMorningside ventureEpigenic therapeuticChan family

vimarsana © 2020. All Rights Reserved.